Company profile: Primrose Bio
1.1 - Company Overview
Company description
- Provider of biotechnology solutions for discovery, development, and manufacturing of new molecules, including Pfenex Expression Technology for high-yield production of complex proteins, Prima RNApols to enhance mRNA yield and quality, PeliCRM197 carrier protein for conjugate vaccines, the Function Generator for novel gene creation, and EOS for enzymatic DNA/RNA oligonucleotide synthesis.
Products and services
- EOS (Enzymatic Oligonucleotide Synthesis): An enzyme-optimized method for manufacturing DNA and RNA oligonucleotides using engineered DNA polymerases, eliminating de-blocking steps and reducing oligonucleotide damage
- Prima RNApols: Custom-engineered RNA polymerases that enhance mRNA production by improving yield and quality while reducing unwanted byproducts
- Pfenex Expression Technology: An industrial-grade protein production platform based on Pseudomonas fluorescens, engineered for high-yield and cost-effective production of complex proteins
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Primrose Bio
Quotient Bioresearch
HQ: United Kingdom
Website
- Description: Provider of tailored, integrated radiochemistry, drug metabolism and e-fate solutions as a leading CRO.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quotient Bioresearch company profile →
Liberation Labs
HQ: United States
Website
- Description: Provider of industrial biotechnology infrastructure for agriculture, offering the Bio3 global precision fermentation platform, high-yield fermentation facilities, efficient fermentation processes with multiple feed capabilities and continuous sterilization, and downstream recovery using centrifugation, microfiltration and ultrafiltration to retain proteins and produce shelf-stable bioproducts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liberation Labs company profile →
Asymchem
HQ: China
Website
- Description: Provider of CDMO and pharmaceutical manufacturing services and biotech solutions, focused on R&D of pharmaceutical raw materials synthesis technology applied to drug development and production, supporting efficient, flexible processes and accelerating the commercial launch of biotech products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Asymchem company profile →
Advantice Health
HQ: United States
Website
- Description: Provider of maximum strength pain relief products and no-touch spray solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advantice Health company profile →
Aragen Bioscience
HQ: United States
Website
- Description: Provider of preclinical contract research and development services specializing in recombinant cell line and hybridoma development, cell culture and protein purification process development and production, mammalian protein expression, primary and immortalized cell-based assays, in vivo models of human disease, custom immunological services, preclinical efficacy studies, and vivarium-based rodent studies including BSL-2 suites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aragen Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Primrose Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Primrose Bio
2.2 - Growth funds investing in similar companies to Primrose Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Primrose Bio
4.2 - Public trading comparable groups for Primrose Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →